Thus, HO-1 and AMPK are possible targets for mitigating BPA-induced neurotoxicity; this provides meaningful references for the development of neurotherapies against BPA-related brain degeneration and cognitive deficits. The gene discussed is HMOX1; the disease is Cognitive impairment.